This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Surrey. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Richard George Leonard Morgan: Innovator in Cancer Biomarkers
Introduction
Richard George Leonard Morgan is a notable inventor based in Surrey, GB. He has made significant contributions to the field of cancer research, particularly in the detection of prostate cancer. His innovative work has the potential to improve diagnostic methods and treatment options for patients.
Latest Patents
Morgan holds a patent for cancer biomarkers, specifically designed for detecting prostate cancer in male subjects. The biomarker comprises at least one homeodomain containing transcription factor, such as a HOX peptide or EN-2 peptide, or a fragment thereof. This invention provides a method for detecting and/or treating prostate cancer, along with associated methods and kits.
Career Highlights
Morgan is affiliated with the University of Surrey, where he continues to advance research in cancer detection and treatment. His work is characterized by a commitment to improving patient outcomes through innovative scientific approaches.
Collaborations
One of his notable collaborators is Hardev Pandha, with whom he has worked on various projects related to cancer biomarkers and treatment methodologies.
Conclusion
Richard George Leonard Morgan's contributions to cancer research through his patented biomarker highlight the importance of innovation in medical science. His work exemplifies the potential for advancements in early detection and treatment of prostate cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile